TransPrEP: Social Network-Based PrEP Adherence for Transgender Women in Peru

Multiple Principal Investigators
Matthew Mimiaga, ScD, MPH
Jesse Lawton Clark, MD (UCLA)
Sari Reisner, ScD (Boston Children’s Hospital/Harvard Medical School)

Sponsor: National Institutes of Health (NIH)/National Institute of Mental Health (NIMH)

Grant Number: 1R34MH104072-01 

This research is to develop a social network-based intervention to promote Pre-Exposure Prophylaxis (PrEP) adherence among PrEP naïve transgender women at risk for HIV infection in Lima, Peru. Once the intervention is developed through multiple forms of qualitative methods, a randomized clinical trial (RCT) pilot will be conducted randomizing by social network-based clusters of transgender women. All participants will be provided with daily Truvada for the study period. The intervention includes a mix of individual counseling, group (peer) based workshops, and social network interactions.